CCR6 and neoplasm: Remarkably, whatever the tumor stage (early [I and II] and advanced [III and IV], the percentages of CD45RO+CCR6+ cells were increased in SD patients as compared to NSND patients (Figure 5A), whereas the percentages of Treg were similar (Figure 5B).